To compare long term speech recognition performance of cochlear implant (CI) recipients with and without hearing preservation. To determine the influence of acoustic representation of 125 Hz on speech recognition with electric-acoustic stimulation (EAS).
What Genes Can Tell: A Closer Look at Vestibular Schwannoma
Ksenia A. Aaron, MD; Zarko Manojlovic, PhD Sharon Chang, BS; Eric Kwok, BS; Nathan Tu, MD, MPH Kyle Hurth, MD, PhD; Rick A. Friedman, MD, PhD Objective: Comprehensive molecular profiling of radioresistant and cystic vestibular schwannoma (VS) subtypes.
Study Design: Our study utilized somatic whole-exome sequencing (WES), RNA-sequencing, and correlated clinical data from 14 selected fresh frozen tumor samples with matched blood.
Setting: Hospital setting research facility.
Patients:
Patients that were diagnosed with VS and necessitated surgery for treatment. Inclusion: Cystic, radioresistant and malignant transformation tumors matched to age and tumor volume, with solid naïve VS samples as control; Exclusion: NF-2 patients.
Intervention(s):
WES was based on the custom probes for more informative copy number analysis, and probes that tile across known regions of known cancer translocations. The DNA, derived from the blood, was utilized as the internal control to reduces false-positive calling. For WES data, we achieved a mean coverage of 124X for VS and for RNA-seq, we generated an average of 80 million read pairs.
Main Outcome Measure(s):
Analysis of genetic landscape of various VS subtypes by performing deep nextgeneration sequencing.
Results:
The mutation rate of cystic, radioresistant and malignant transformation samples had drastically higher number of non-silent mutations vs the naïve (p=0.0014). In addition to already published data, such as frequency of 22q loss, somatic mutational analysis unraveled significantly mutated genes such as FOXD4, IGFN1, FNM2, NOTCH4 and ALK.
Conclusions: High quality, high-resolution WES allowed us to identify potential differences in the genomic and molecular landscape of cystic and radioresistant VS. Our results can help advance the understanding of the pathophysiology of these tumor subtypes and pinpoint the molecular targets for alternative treatment strategies.
Define Professional Practice Gap & Educational Need:
Approximately 10% of vestibular schwannomas (VS) display either cystic and radioresistant features. These VS tumor subtypes are a different clinical entity as they are usually characterized by unpredictable biologic behavior with frequent involvement of cranial nerves and a relatively rapid rate of growth. There is a lack of knowledge in the precise etiology of these VS subtypes, even though various mechanisms have been proposed.
Learning Objective:
Using high-quality, high-resolution whole-exome sequencing to evaluate molecular profiling of radioresistant and cystic VS.
Desired Result:
Results from our study can help advance our understanding of the pathophysiology of these VS tumor subtypes and pinpoint the molecular targets in alternative treatments.
Level of Evidence -Level III -Cohort and case-control studies
Indicate IRB or IACUC Approval: Approved
NEUROTOLOGY FELLOW AWARD

Effects of Single-Fraction Radiation on Merlin-Deficient and Normal Schwann Cells in Vitro
Erin R. Cohen, MD; Brian Marples, PhD Nagy Elsayyad, MD; Michael Ivan, MD Cristina Fernandez-Valle, PhD; Fred F. Telischi, MD Christine T. Dinh, MD Background: Vestibular schwannomas are benign tumors of the cochleovestibular nerve that develop from NF2 mutations leading to merlin dysfunction and/or loss. Although tumor control rates with stereotactic radiosurgery are >85% at 10 years, hearing preservation rates approach 25%. The first steps toward optimizing radiation protocols are determining the molecular and cellular effects of radiation on wild type (WT-SC) and merlin-deficient Schwann cells (MD-SC).
Hypothesis: WT-SCs are more resistant to specific dosages of single fraction (SF) radiation than MD-SCs through differential expression of apoptosis, DNA damage and repair.
Methods: Human and murine WT-SCs and MD-SCs were seeded on 96-well plates and 16-well culture slides and treated with SF-radiation (0-18 Gy). Cell-based assays were performed to assess viability, cytotoxicity, and apoptosis.
Immunohistochemistry was performed to determine expression of DNA breaks and activation of DNA repair mechanisms.
Statistical analysis was performed with Mann-Whitney U and Kruskal-Wallis tests.
Results: SF-radiation initiated double-strand DNA breaks in all cell-lines; however, there was differential activation of DNA repair mechanisms, cleaved caspase-3/7 expression, and loss of membrane integrity. Rat WT-SCs demonstrated remarkable resistance to SF radiation. In contrast, human WT-SCs demonstrated dose-dependent reductions in viabilities. Viabilities, however, were significantly better than human and mouse MD-SCs at several radiation dosages.
Conclusion: MD-SCs are more susceptible to SF-radiation-induced loss than WT-SCs. WT-SCs may activate multiple DNA repair mechanisms to evade radiation injury at specific radiation dosages. Further investigations into the radiobiology of vestibular schwannoma and normal nerve are critical in understanding and improving clinical outcomes in the future.
Define Professional Practice Gap & Educational Need: 1. The most optimal stereotactic radiosurgery protocol to maximize tumor control and hearing preservations rates in sporadic vestibular schwannoma is controversial. 2. There is a need to understand how radiation affects vestibular schwannoma and adjacent normal nerve on molecular and cellular levels to identify better radiation strategies to maximize tumor control and hearing preservations rates.
Learning Objective: Addressing both 1 and 2 above, we aim to understand the differences in radiobiological response of normal and pathological merlin-deficient Schwann cells that can potentially affect clinical outcomes when treating vestibular schwannoma.
Desired Result: -Gain in physician knowledge that radiation causes cellular injury by initiating double-strand DNA breaks at specific radiation dosages. -Gain in physician knowledge that evasion of radiation injury can occur through activation of DNA repair mechanisms. -Gain in physician knowledge of how understanding the radiobiology of vestibular schwannoma and adjacent nerve constituents can aid in identifying radiation protocols that can improve clinical outcomes.
Level of Evidence -Does not apply-you will be asked to explain -in vitro study
Indicate IRB or IACUC Approval: Exempt Background: Animal studies show that cell loss in the spiral ligament precedes loss of hair cells and/or neurons, suggesting fibrocyte pathology as the primary cause of sensory cell degeneration. However, involvement of other structures confounds the role of spiral ligament.
Methods: Sixty-nine temporal bones from patients with varying degrees of SNHL or normal hearing, having normal cochlear sensorineural structures, were studied using quantitative evaluation of spiral ligament fibrocytes under light microscopy. Double staining with hematoxylin was used to quantify fibrocytes of each type. Fibrocyte quantity was compared between SNHL and normal hearing, and correlation coefficients were computed between PTA and fibrocyte counts. Expression of ion transport mediating enzymes Na,K-ATPase, CAII , CK, and connexin 26 was assessed by immunohistochemistry to evaluate fibrocyte function.
Results: All correlations between PTA and spiral ligament were negative; the fewer the fibrocytes, the poorer the hearing (higher PTA). Five of 25 comparisons achieved significance, primarily in middle cochlear turn segments.
Significant correlation coefficients (all p's<.05) were small to moderate (-.347 to-.428), increasing when including only subjects tested within two years of death (-.472 to -.558). Preliminary results using CAII antibody and double hematoxylin staining suggest functionality of fibrocytes may be a more important factor.
Conclusions:
Fibrocyte quantity may be a contributing factor to hearing loss severity in humans, but explains only a portion of variability in SNHL. Fibrocyte functionality may be a more critical factor, but further study is required.
Define Professional Practice Gap & Educational Need:
Lack of contemporary knowledge.
Learning Objective: Papers reporting data on animals have suggested that cell loss in the spiral ligament precedes the loss of hair cells and/or neurons in both space and time suggesting that fibrocyte pathology may be the primary cause of the hearing loss and ultimate sensory cell degeneration in animals, but this has not been shown in humans. Previous studies by our institution have suggested that the spiral ligament may play a role in sensorineural hearing loss (SNHL) but the involvement of other structures (stria vascularis, hair cells, dendrites, spiral ganglion cells, endolymphatic sac) in those cases makes it difficult to asses whether the hearing loss was caused by degeneration of those structures or if the spiral ligament pathology was the primary cause of hearing loss, as proposed by others. Therefore, the learning objective of the present study is to determine whether spiral ligament fibrocyte pathology may be a primary cause of SNHL in humans. Temporal bones from patients with varying degrees of SNHL will be selected after exclusion of other possible causes of SNHL, such as hair cell degeneration, loss of dendrites, or decreased spiral ganglion counts. Temporal bones of patients with normal hearing and normal inner ear structures will be used for comparison.
Desired Result: The study will help attendees understand the concept that spiral ligament fibrocyte pathology may be the primary cause of sensorineural hearing loss (SNHL) and that fibrocyte quantity may be a contributing factor to hearing loss severity in humans, but explains only a portion of variability in SNHL. Fibrocyte functionality may be a more critical factor, but further study is required.
